IDEXX Laboratories, Inc. (IDXX)
IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript
IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript
IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise
IDXX tops Q4 EPS and revenue estimates as margins expand. However, shares dip during the pre-market trading, while 2026 guidance calls for steady growth.
Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates
Idexx Laboratories (IDXX) came out with quarterly earnings of $3.08 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.62 per share a year ago.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
Curious about Idexx (IDXX) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Idexx (IDXX) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings
Ahead of Q4 earnings, IDXX eyes double-digit revenue and EPS growth, driven by CAG momentum, new diagnostics and steady Water gains.
Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now?
IDXX rides on strong CAG Diagnostics momentum and growing global software adoption, but currency pressure and solvency risks cloud the outlook.
IDEXX Stock Up 64.7% in a Year: What's Driving the Growth?
IDXX shares surge 64.7% in a year as CAG Diagnostics momentum, strong retention and expanding software adoption fuel growth across regions.
3 ESG Stocks to Add to Your Portfolio for Sustainable Returns in 2026
NVIDIA, IDXX and Microsoft shine on ESG metrics, fueling investor interest with strong returns and ambitious 2030 goals.
